Abstract:B-type natriuretic peptide levels were markedly elevated at presentation in the acute care setting for all patients in this cohort of children with newly diagnosed congenital or acquired heart disease. B-type natriuretic peptide levels from noncardiac patients were significantly lower, with no overlap to the cardiac disease group. B-type natriuretic peptide level can be useful as a diagnostic marker to aid in the recognition of pediatric critical heart disease in the acute care setting.
“…Many cardiac disease states (ventricular septal defect (VSD), patent ductus arteriosus (PDA), coarctation of aorta, cardiomyopathy…etc ) can mimic the more common illnesses of childhood, such as bronchiolitis, reactive airway disease and sepsis (1). Acute bronchiolitis, one of the most common disease of this group, is most commonly seen in children under two years of age.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…Because of that a sensitive, reachable marker to aid in the recognition of heart disease and lung disease in children will be useful (1).…”
“…Many cardiac disease states (ventricular septal defect (VSD), patent ductus arteriosus (PDA), coarctation of aorta, cardiomyopathy…etc ) can mimic the more common illnesses of childhood, such as bronchiolitis, reactive airway disease and sepsis (1). Acute bronchiolitis, one of the most common disease of this group, is most commonly seen in children under two years of age.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…Because of that a sensitive, reachable marker to aid in the recognition of heart disease and lung disease in children will be useful (1).…”
“…В частности, в когортном иссле-довании медицинского центра США (англ. Children's Healthcare of Atlanta) выявили достоверное увеличение BNP в группе детей с кардиологической патологией (в том числе с ВПС) в сравнении с детьми без патологии сердца [24,25]. Другое исследование, опубликован-ное Law Y.M.…”
Section: клиническая значимость натрийуретических пептидов в диагностunclassified
<p class="a">Natriuretic peptides (NUP) are peptide hormones secreted by cardiomyocytes in response to a volume overload of the heart. Emphasis in the article is placed on the history of NUP discovery, their chemical structure and pathophysiological mechanisms of action. The data on determination of NUP reference values in children with cardiac pathologies are analyzed. A NUP clinical significance in early diagnosis of heart failure in children, including those with congenital heart defects is shown. Also considered is NUP dynamics after surgical correction of congenital heart defects. A conclusion is drawn that NUP play an important prognostic role in evaluating early and late postoperative periods and disease outcomes on a whole.</p><p align="JUSTIFY">Received 11 October 2016. Accepted 22 December 2016.</p><p align="JUSTIFY"><strong>Funding: </strong>The study had no sponsorship.</p><p align="JUSTIFY"><strong>Conflict of interest: </strong>The authors declare no conflict of interest.</p><p align="JUSTIFY"><strong>Author contributions</strong></p><p align="JUSTIFY">All authors contributed equally at all stages of the research.</p>
“…(36) ■ to discriminate serious from non-serious disease among children with newly diagnosed cardiac disease. (37) Also, BNP and NT-proBNP levels are higher in children with newly diagnosed heart failure or those with acute exacerbations of chronic heart failure; higher BNP levels predict poor prognosis; improved BNP levels suggest improved ventricular function; following complex heart surgery, BNP is predictive of heart failure and BNP might be helpful as a marker of anthracycline induced myocardial toxicity. (38)(39)(40)(41)(42)(43) Other studies…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.